Intellia Therapeutics Inc buy Truist Financial Co.
Start price
04.03.25
/
50%
€8.43
Target price
04.03.26
€47.44
Performance (%)
40.77%
Price
04.03.26
€11.87
This prediction will end soon
Summary
This prediction is currently active. With a performance of 40.77% the BUY prediction by Truist_Financial_Co_ is a big success. This prediction currently runs until 04.03.26. The prediction end date can be changed by Truist_Financial_Co_ at any time. Truist_Financial_Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Intellia Therapeutics Inc | 4.443% | 4.443% | 38.474% |
| iShares Core DAX® | -3.809% | -1.472% | 6.060% |
| iShares Nasdaq 100 | 0.487% | 2.215% | 12.682% |
| iShares Nikkei 225® | -4.418% | 4.971% | 30.914% |
| iShares S&P 500 | 0.251% | 1.225% | 9.374% |
Comments by Truist_Financial_Co_ for this prediction
In the thread Intellia Therapeutics Inc diskutieren
Intellia Therapeutics, Inc. (NASDAQ: NTLA) had its price target lowered by analysts at Truist Financial Co. from $90.00 to $50.00. They now have a "buy" rating on the stock.
Ratings data for NTLA provided by MarketBeat
Stopped prediction by Truist_Financial_Co_ for Intellia Therapeutics Inc
Intellia Therapeutics Inc
Start price
Target price
Perf. (%)
€8.65
10.11.25
10.11.25
€12.11
10.11.26
10.11.26
37.29%
04.03.26
04.03.26
Intellia Therapeutics Inc
Start price
Target price
Perf. (%)
€23.43
24.06.24
24.06.24
€111.85
24.06.25
24.06.25
-64.98%
25.06.25
25.06.25